David L Mahoney - Net Worth and Insider Trading
David L Mahoney Net Worth
The estimated net worth of David L Mahoney is at least $31 Million dollars as of 2024-04-19. David L Mahoney is the Director of Corcept Therapeutics Inc and owns about 1,233,375 shares of Corcept Therapeutics Inc (CORT) stock worth over $28 Million. David L Mahoney is the Director of Gen Digital Inc and owns about 137,840 shares of Gen Digital Inc (GEN) stock worth over $3 Million. David L Mahoney is also the Director of Adamas Pharmaceuticals Inc and owns about 10,674 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $87,740. Details can be seen in David L Mahoney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David L Mahoney has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).
Transaction Summary of David L Mahoney
David L Mahoney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David L Mahoney owns 3 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Corcept Therapeutics Inc (CORT) , and Gen Digital Inc (GEN) .
Click here to see the complete history of David L Mahoney’s form 4 insider trades.
Insider Ownership Summary of David L Mahoney
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2020-06-03 | director |
| CORT | Corcept Therapeutics Inc | 2023-08-14 | director |
| GEN | Gen Digital Inc | 2014-12-15 | director |
David L Mahoney Latest Holdings Summary
David L Mahoney currently owns a total of 3 stocks. Among these stocks, David L Mahoney owns 1,233,375 shares of Corcept Therapeutics Inc (CORT) as of August 14, 2023, with a value of $28 Million and a weighting of 90.62%. David L Mahoney owns 137,840 shares of Gen Digital Inc (GEN) as of December 15, 2014, with a value of $3 Million and a weighting of 9.1%. David L Mahoney also owns 10,674 shares of Adamas Pharmaceuticals Inc (ADMS) as of April 9, 2014, with a value of $87,740 and a weighting of 0.28%.
Latest Holdings of David L Mahoney
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2023-08-14 | 1,233,375 | 22.68 | 27,972,945 |
| GEN | Gen Digital Inc | 2014-12-15 | 137,840 | 20.38 | 2,809,179 |
| ADMS | Adamas Pharmaceuticals Inc | 2014-04-09 | 10,674 | 8.22 | 87,740 |
Holding Weightings of David L Mahoney
David L Mahoney Form 4 Trading Tracker
According to the SEC Form 4 filings, David L Mahoney has made a total of 1 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 25,000 shares on August 14, 2023, which brought David L Mahoney around $773,750.
According to the SEC Form 4 filings, David L Mahoney has made a total of 0 transactions in Gen Digital Inc (GEN) over the past 5 years. The most-recent trade in Gen Digital Inc is the sale of 12,000 shares on December 15, 2014, which brought David L Mahoney around $303,960.
According to the SEC Form 4 filings, David L Mahoney has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 0 shares on April 9, 2014, which brought David L Mahoney around $0.
Insider Trading History of David L Mahoney
- 1
David L Mahoney Trading Performance
GuruFocus tracks the stock performance after each of David L Mahoney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David L Mahoney is 6.73%. GuruFocus also compares David L Mahoney's trading performance to market benchmark return within the same time period. The performance of stocks bought by David L Mahoney within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David L Mahoney's insider trading performs compared to the benchmark.
Performance of David L Mahoney
Average Return
-1.55%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.44 | 6.73 | -17.38 | -1.55 | -15.84 | -4.27 |
| Relative Return to S&P 500(%) | 10.71 | 5.98 | -18.53 | -2.6 | -19.79 | -2.34 |
David L Mahoney Ownership Network
Ownership Network List of David L Mahoney
Ownership Network Relation of David L Mahoney
David L Mahoney Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
David L Mahoney is the director of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
David L Mahoney Mailing Address
Above is the net worth, insider trading, and ownership report for David L Mahoney. You might contact David L Mahoney via mailing address: Symantec Corporation, 20330 Stevens Creek Blvd., Cupertino Ca 95014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
